![](https://news.europawire.eu/wp-content/uploads/2024/10/Breakthrough-Peptide-Inhibitor-Targets-Tau-Protein-Aggregation-Paving-the-Way-for-New-Alzheimers-Treatments-144x144.png)
(IN BRIEF) An international team of researchers has made a significant breakthrough in Alzheimer’s drug development with the introduction of RI-AG03, a novel peptide inhibitor that targets and inhibits two key aggregation-promoting hotspots of the Tau protein, which is critical … Read the full press release